NCT05078723 CYP2C19 Variants and Limonene Metabolism
| NCT ID | NCT05078723 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | CYP2C19 Genetic Variants |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2021-10-30 |
| Primary Completion | 2026-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2021-10-30 with a primary completion date of 2026-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators will examine whether a non-invasive screening tool for CYP2C19 genetic variants can be developed by measuring limonene metabolism.
Eligibility Criteria
Inclusion Criteria: * Age range: Greater than 18 years and less than 45 years. * Gender: Male or Female * Ethnicities: East Asian Exclusion Criteria: * Pregnant and/or Breastfeeding * previous allergic reaction to limonene, citrus fruits, bovine gelatin, glycerin * past medical history of cerebrovascular or cardiovascular disease * veganism * history of chest pain or shortness of breath in the past month * certain medications that are CYP2C19 substrates or CYP2C19 inhibitors * Non-East Asian descent * age less than 18 y.o or age greater than 45 y.o
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05078723 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying CYP2C19 Genetic Variants. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05078723 currently recruiting?
Yes, NCT05078723 is actively recruiting participants. Contact the research team at ergross@stanford.edu for enrollment information.
Where is the NCT05078723 trial being conducted?
This trial is being conducted at Stanford, United States.
Who is sponsoring the NCT05078723 clinical trial?
NCT05078723 is sponsored by Stanford University. The trial plans to enroll 20 participants.